The Janssen Pharmaceutical Companies of Johnson & Johnson announced today their entry into a worldwide collaboration with an affiliate of...
Read moreRoche announced results from the positive Phase III IMmotion151 study of TECENTRIQ® (atezolizumab) and Avastin® (bevacizumab) as a first-line treatment...
Read moreShire plc , the global biotechnology leader in rare diseases, today announced the range of real-world and long-term research it...
Read moreShire plc the global biotechnology leader in rare diseases, today announced that it will have 12 presentations, including 11 posters...
Read moreCelgene Corporation announced that the Phase III, randomized, open-label, international clinical study, OPTIMISMM, achieved its primary endpoint, showing a statistically...
Read moreDaiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in a phase 1 study...
Read moreAllergan plc , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two...
Read moreTeva Pharmaceutical Industries Ltd. announced it has completed the sale of a portfolio of products within its global women’s health...
Read moreTeva Pharmaceutical Industries Ltd. announced amendments to its USD and JPY term loan and revolving credit facilities, providing the company...
Read moreResearchers recommend changes to international guidelines used in the development of clinical trials in an effort to obtain useful information...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.